High serum CXCL13 levels are predictive of treatment failure with first-line MTX among patients with early RA.

A once-daily dose of ivarmacitinib reduced disease activity and improved function among patients with rheumatoid arthritis ...

Study to determine which treatments best for which inflammatory arthritis patients should result in patients being better ...

Nurse-led care effectively reduces disease activity and improves self-efficacy in patients with rheumatoid arthritis, ...

As GLP-1 RA use soars, experts are worried that patients may not be getting the right nutrients in their diets. How can ...

RA treatment aims to decrease inflammation, which decreases symptoms (pain/discomfort and stiffness), and lessens the risk of joint damage. By limiting joint damage, disability is reduced. The primary ...

Hangzhou Sciwind Biosciences Co., a pre-commercial biopharmaceutical company focusing on developing innovative therapies to treat metabolic diseases, today announced a licensing and collaboration ...

Cullinan offers promising oncology and autoimmune products, strong financials, and potential for growth, making it a ...

Background: Effective treatment of active rheumatoid arthritis (RA) requires early diagnosis and early disease modifying antirheumatic drug (DMARD) treatment to have an impact on long term morbidity ...

My dentist explained that using a water flosser lessens the amount of fine motor movement necessary to get in between teeth.